Stereotactic ablative Radiotherapy in Patients with oligometastatic Prostate Cancer

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE UROLOGIE | 2021年 / 52卷 / 01期
关键词：
D O I：
10.1055/a-1170-9469
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Das metastasierte Prostatakarzinom ist nicht heilbar. Stellt die stereotaktische ablative Radiotherapie (SABR) fur Patienten mit einer Oligometastasierung eine effektive Alternative zur nebenwirkungsreichen Androgenentzugstherapie dar? Dieser Frage ging ein Team von US-Wissenschaftlern im Rahmen der ORIOLE-Studie nach.
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [41] Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
    Karel Decaestecker
    Gert De Meerleer
    Bieke Lambert
    Louke Delrue
    Valérie Fonteyne
    Tom Claeys
    Filip De Vos
    Wouter Huysse
    Arne Hautekiet
    Gaethan Maes
    Piet Ost
    Radiation Oncology, 9
  • [42] Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
    Patel, Priyanka H.
    Chaw, Cheng Lee
    Tree, Alison C.
    Sharabiani, Mansour
    van As, Nicholas J.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (12) : 2615 - 2621
  • [43] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [44] VMAT Stereotactic Ablative Radiotherapy for oligometastatic patients: role of FDG PET/CT
    BORGHES, S., I
    Gasperi, C.
    Terziani, F.
    Curion, A. S.
    Rampini, A.
    Pernici, P.
    Bertocci, S.
    Gennari, P. G.
    Iermano, C.
    De Majo, R.
    Losardo, P. L.
    Tucci, E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1227 - S1228
  • [45] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
  • [46] STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OLIGOMETASTATIC PROSTATE CANCER PATIENTS: A SINGLE INSTITUTION EXPERIENCE
    Bruni, Alessio
    Mazzeo, Ercole
    Lanfranchi, Biancaluisa
    Rubino, Laura
    Lamin, Laroussi Mohammed
    Mucciarini, Claudia
    Nicolini, Massimiliano
    Lohr, Frank
    Giacobazzi, Patrizia
    ANTICANCER RESEARCH, 2016, 36 (05) : 2566 - 2567
  • [47] Stereotactic body radiotherapy in 117 oligometastatic lymph node recurrent prostate cancer patients
    Fanetti, G.
    Jereczek-Fossa, B. A.
    Fodor, C.
    Francia, C. M.
    Zerini, D.
    Surgo, A.
    Muto, M.
    Gerardi, M. A.
    Dicuonzo, S.
    Cambria, R.
    Garibaldi, C.
    Pansini, F.
    Bazani, A.
    De Cobelli, O.
    Orecchia, R.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S639 - S640
  • [48] Stereotactic ablative radiotherapy for low to intermediate risk prostate cancer
    Sadozye, A.
    Dodds, D.
    MacLeod, N.
    Lamb, C.
    Smith, S.
    Foster, J.
    Devlin, L.
    Dufton, A.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S680
  • [49] Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease
    Salim, Nidal
    Tumanova, Kristina
    Popodko, Alexey
    Libson, Evgeny
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [50] CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
    Kataria, Tejinder
    Naga, Pushpa
    Banerjee, Susovan
    Gupta, Deepak
    Narang, Kushal
    Tayal, Manoj
    Bisht, Shyam Singh
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (02) : 107 - 111
12345